The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations
Abstract Introduction: Ideally, real-world data (RWD) collected to generate real-world evidence (RWE) should lead to impact on the care and health of real-world patients. Deriving from care in which clinicians and patients try various treatments to inform therapeutic decisions, N-of-1 trials bring...
Main Authors: | Harry P. Selker, Dorothy Dulko, David J. Greenblatt, Marisha Palm, Ludovic Trinquart |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-01-01
|
Series: | Journal of Clinical and Translational Science |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866123006040/type/journal_article |
Similar Items
-
Editorial: Real-world data and real-world evidence in hematologic malignancies
by: Michele Malagola, et al.
Published: (2023-06-01) -
Real-world evidence: What is it and why does it matter to pharmacists?
by: Usman Abubakar Haruna, et al.
Published: (2023-03-01) -
Harnessing Real-World Evidence to Advance Cancer Research
by: Monica Tang, et al.
Published: (2023-02-01) -
Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making
by: Katkade VB, et al.
Published: (2018-07-01) -
Methods for the inclusion of real-world evidence in network meta-analysis
by: David A. Jenkins, et al.
Published: (2021-10-01)